Sprint Bioscience will present results from the TREX1 program and will participate with a poster at the AACR IO Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy conference, to be held in Los Angeles, California, February 23-26, 2025. Read more about the conference here. here.